ATE411811T1 - Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie - Google Patents

Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie

Info

Publication number
ATE411811T1
ATE411811T1 AT00913818T AT00913818T ATE411811T1 AT E411811 T1 ATE411811 T1 AT E411811T1 AT 00913818 T AT00913818 T AT 00913818T AT 00913818 T AT00913818 T AT 00913818T AT E411811 T1 ATE411811 T1 AT E411811T1
Authority
AT
Austria
Prior art keywords
ophthalmology
synthetic peptides
complementary synthetic
peptides
complementary
Prior art date
Application number
AT00913818T
Other languages
English (en)
Inventor
Jeffrey Haddox
James Blalock
Robert Pfister
Matteo Villain
Original Assignee
Fornix Biosciences N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fornix Biosciences N V filed Critical Fornix Biosciences N V
Application granted granted Critical
Publication of ATE411811T1 publication Critical patent/ATE411811T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT00913818T 1999-03-09 2000-03-08 Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie ATE411811T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12340999P 1999-03-09 1999-03-09

Publications (1)

Publication Number Publication Date
ATE411811T1 true ATE411811T1 (de) 2008-11-15

Family

ID=22408525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00913818T ATE411811T1 (de) 1999-03-09 2000-03-08 Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie

Country Status (8)

Country Link
US (2) US6310041B1 (de)
EP (1) EP1560590B1 (de)
AT (1) ATE411811T1 (de)
AU (1) AU3518700A (de)
CA (1) CA2366678A1 (de)
DE (1) DE60040623D1 (de)
ES (1) ES2316356T3 (de)
WO (1) WO2000053621A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138692A1 (de) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren
US20040202645A1 (en) * 2003-04-08 2004-10-14 Khan Nisar Ahmed Administration of gene-regulatory peptides
US6921751B1 (en) * 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US6310041B1 (en) * 1999-03-09 2001-10-30 Fornix Biosciences N.V. Synthetic complementary peptides and ophthalmologic uses thereof
NL1011737C2 (nl) * 1999-04-06 2000-10-09 Ct For Immunopharmacology Verbinding voor het remmen van de influx van polymorphonucleaire leukocyten (PMNs) in een weefsel, werkwijze voor het selecteren van een dergelijke verbinding, een farmaceutisch preparaat en een toepassing van de verbinding.
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20030220260A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Peptide compositions
US7501391B2 (en) * 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US20030224995A1 (en) * 2001-12-21 2003-12-04 Khan Nisar Ahmed Treatment of burns
US20040013661A1 (en) * 2001-12-21 2004-01-22 Gert Wensvoort Stratification
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US20030220261A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Treatment of iatrogenic disease
WO2003102195A1 (en) * 2002-06-04 2003-12-11 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
AU2006266609C1 (en) * 2005-07-05 2011-10-27 Biotempt B.V. Treatment of tumors
WO2007035406A1 (en) 2005-09-16 2007-03-29 Orthologic Corp. Antibodies to complementary peptides of thrombin or portions thereof
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
KR101247641B1 (ko) 2010-10-22 2013-03-29 성균관대학교산학협력단 Ｃｘｃｒ２에 결합하는 펩타이드 리간드를 포함하는 감염성 및 염증성 질환 치료용 조성물
WO2017217728A1 (ko) * 2016-06-13 2017-12-21 부산대학교 산학협력단 Ac-pgp 펩타이드를 유효성분으로 포함하는 혈관 신생 촉진용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077195A (en) * 1985-03-01 1991-12-31 Board Of Reagents, The University Of Texas System Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity
WO2000047606A1 (fr) * 1999-02-12 2000-08-17 Kyowa Hakko Kogyo Co., Ltd. Peptides inhibant la migration des cellules endotheliales vasculaires
US6310041B1 (en) * 1999-03-09 2001-10-30 Fornix Biosciences N.V. Synthetic complementary peptides and ophthalmologic uses thereof
NL1011737C2 (nl) * 1999-04-06 2000-10-09 Ct For Immunopharmacology Verbinding voor het remmen van de influx van polymorphonucleaire leukocyten (PMNs) in een weefsel, werkwijze voor het selecteren van een dergelijke verbinding, een farmaceutisch preparaat en een toepassing van de verbinding.

Also Published As

Publication number Publication date
EP1560590A2 (de) 2005-08-10
US6762166B2 (en) 2004-07-13
ES2316356T3 (es) 2009-04-16
US20020107202A1 (en) 2002-08-08
EP1560590B1 (de) 2008-10-22
US6310041B1 (en) 2001-10-30
AU3518700A (en) 2000-09-28
WO2000053621A2 (en) 2000-09-14
EP1560590A4 (de) 2005-08-10
CA2366678A1 (en) 2000-09-14
WO2000053621A3 (en) 2005-06-16
DE60040623D1 (de) 2008-12-04

Similar Documents

Publication Publication Date Title
ATE411811T1 (de) Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie
DE3787002T2 (de) Synthetische Peptide, die zelluläre Immunität gegen den AIDS-Virus und dessen Proteine erzeugen.
DE69434181D1 (de) Therapeutische Peptid Derivate
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DE69616480T2 (de) Piperidinderivate als neurokininantagonisten
EA199900598A1 (ru) Производные 1-арил- и пиридилпиразола с пестицидными свойствами
FI962591A (fi) Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
DE60331546D1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
RS49517B (sr) PEPTID p277-ANALOZI I FARMACEUTSKI PREPARATI KOJI GA SADRZE
ATE407947T1 (de) Proteine mit il-6 inhibitorischer wirkung
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DE60208180D1 (de) Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung
DE68917837D1 (de) Peptid-Verbindungen.
ATE211765T1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
ATE414100T1 (de) Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
ATE201693T1 (de) Hämoregulierende peptide
BR9814188A (pt) "agonistas de 5-ht1f"
TR200401875T2 (tr) Endoparazit öldürücü bileşimler
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
FI20012082A0 (fi) Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi
BR9611904A (pt) Dioxidos de ditiazol
TR199800850T2 (xx) Kan� d�zenleyici bile�imler.
LT2002131A (en) New use of fir oil for cosmetic
DE69937998D1 (de) Antiproliferative und antivirale proteine und peptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties